TORONTO, Jan. 29, 2018 (GLOBE NEWSWIRE) -- Eurocontrol Technics Group Inc. (TSX-V:EUO) (OTCQB:EUCTF) (“Eurocontrol” or the “Company”), a Canadian public company specializing in the acquisition, development and commercialization of innovative test and measurement technologies for industry with application systems focused on the growing precision agriculture and semiconductor sectors, announces that its subsidiary Croptimal has entered into a Memorandum of Understanding (“MOU”) with Canndoc Ltd. (“Canndoc”), a leading Israeli medical Cannabis company since 2009 to form a joint venture company that will be called “CropCan” and will be owned 50/50 by Croptimal and Canndoc to market a service utilizing Croptimal’s unique in-field measurement tools, together with an innovative system of big database analysis (machine learning) and Canndoc’s expertise in the field of growing medical Cannabis.
Croptimal offers a suite of in-field decision support tools to agronomists and farmers based on an innovative system of big database analysis (machine learning) utilizing unique hardware and software that enables continuous measurement of nutrients in soil, water and plant tissue to provide accurate fertilization recommendations within 10 minutes. Canndoc is an Israeli company licensed by the Israeli Ministry of Health to grow, process, sell and distribute medical grade Cannabis to licensed patients. Canndoc is a leader in the Israeli medical Cannabis industry with expertise in breeding, genetics, tissue culturing R&D, production and harvesting methods and protocols for dehydration and curing of Cannabis plants including the extraction of specific active ingredients. This expertise has resulted in the development of a comprehensive and unique method for cultivation and production of medical grade Cannabis in all facets of the value chain which are being supplied to thousands of patients in Israel since its inception. The cooperation between Croptimal and Canndoc will enable CropCan, the new joint venture company that will be formed, to offer dynamic growth protocols for the medical Cannabis industry to increase crop yields in this fast-growing and unique market.
Israel has become the epicenter of medical Cannabis research which commenced with research in the 1960’s undertaken by Raphael Mechoulam, an Israeli organic chemist and professor of Medicinal Chemistry at the Hebrew University of Jerusalem who is known worldwide as a leading pioneer in Cannabis research. Israel was one of the first countries to legalize medicinal use and to institute a government-supported medical Cannabis program placing Israel at the forefront in this field and a global destination for medical Cannabis research and development testing the benefits of medicinal Cannabis - https://www.youtube.com/watch?v=neJb224HUC0&feature=youtu.be.
Doron Reinis, COO of Eurocontrol and CEO of Croptimal stated: “With numerous companies in the Cannabis industry looking to Israel for Cannabis R&D, we believe our collaboration with Canndoc will place Croptimal in a strong position to leverage its unique hybrid technologies beyond Israel’s borders as the Cannabis industry responds quickly to consumer needs.”
Avner (Neri) Barak, co-Founder and President of Canndoc added, “Canndoc is very pleased to join forces with Croptimal. The ability to have a complete full range of in-field measurement tools and dynamic growth protocols for the Cannabis industry will improve crop quality. Our ability as cultivators to get real time lab results will allow for much better control and the ability to adjust growing practices according to real time reflection of crop health.”